Beatrix Kotlán

560 total citations
25 papers, 272 citations indexed

About

Beatrix Kotlán is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Beatrix Kotlán has authored 25 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 14 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Molecular Biology. Recurrent topics in Beatrix Kotlán's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Immunotherapy and Immune Responses (9 papers) and Glycosylation and Glycoproteins Research (8 papers). Beatrix Kotlán is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Immunotherapy and Immune Responses (9 papers) and Glycosylation and Glycoproteins Research (8 papers). Beatrix Kotlán collaborates with scholars based in Hungary, United States and France. Beatrix Kotlán's co-authors include Mark C. Glassy, Jean‐Luc Teillaud, Wolf H. Fridman, József Tóth, Francesco M. Marincola, David F. Stroncek, J. Földi, Nadège Gruel, É Gyódi and David I. Stott and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Frontiers in Immunology.

In The Last Decade

Beatrix Kotlán

23 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beatrix Kotlán Hungary 11 186 111 79 70 23 25 272
P. G. Natali United States 9 181 1.0× 61 0.5× 84 1.1× 110 1.6× 15 0.7× 19 337
Fernanda Castro United Kingdom 6 145 0.8× 64 0.6× 40 0.5× 89 1.3× 26 1.1× 8 242
Dave Ankarlo United States 4 427 2.3× 226 2.0× 49 0.6× 63 0.9× 7 0.3× 4 491
Robin Goldman-Leikin United States 9 72 0.4× 100 0.9× 205 2.6× 79 1.1× 18 0.8× 13 339
Cornelia Mundt United Kingdom 9 298 1.6× 54 0.5× 61 0.8× 95 1.4× 21 0.9× 12 378
Diana Handke Germany 9 274 1.5× 208 1.9× 23 0.3× 140 2.0× 16 0.7× 17 438
Oezcan Talay United States 7 281 1.5× 136 1.2× 24 0.3× 28 0.4× 7 0.3× 11 377
Wilson Castro United States 10 290 1.6× 64 0.6× 11 0.1× 68 1.0× 7 0.3× 16 347
Thomas O. Kleen United States 6 170 0.9× 159 1.4× 15 0.2× 55 0.8× 6 0.3× 7 284
Donna LeBherz United States 6 111 0.6× 131 1.2× 186 2.4× 92 1.3× 7 0.3× 8 326

Countries citing papers authored by Beatrix Kotlán

Since Specialization
Citations

This map shows the geographic impact of Beatrix Kotlán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatrix Kotlán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatrix Kotlán more than expected).

Fields of papers citing papers by Beatrix Kotlán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatrix Kotlán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatrix Kotlán. The network helps show where Beatrix Kotlán may publish in the future.

Co-authorship network of co-authors of Beatrix Kotlán

This figure shows the co-authorship network connecting the top 25 collaborators of Beatrix Kotlán. A scholar is included among the top collaborators of Beatrix Kotlán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beatrix Kotlán. Beatrix Kotlán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rutella, Sergio, Michael A. Cannarile, Sacha Gnjatic, et al.. (2020). Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I—conceptual challenges. Journal for ImmunoTherapy of Cancer. 8(2). e001389–e001389. 10 indexed citations
2.
Cesano, Alessandra, Michael A. Cannarile, Sacha Gnjatic, et al.. (2020). Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume II—practical challenges. Journal for ImmunoTherapy of Cancer. 8(2). e001472–e001472. 5 indexed citations
3.
4.
Kotlán, Beatrix, Gabriella Liszkay, Miri Blank, et al.. (2014). The novel panel assay to define tumor-associated antigen-binding antibodies in patients with metastatic melanomas may have diagnostic value. Immunologic Research. 61(1-2). 11–23. 3 indexed citations
5.
Bleck, Gregory T., Rishab K. Gupta, Beatrix Kotlán, Dona York, & Mark C. Glassy. (2014). Abstract 2658: GPEx® system to increase production of pritumumab in a CHO cell line. Cancer Research. 74(19_Supplement). 2658–2658. 3 indexed citations
6.
Kotlán, Beatrix, Gabriella Liszkay, Szabolcs Horváth, et al.. (2014). Revealing cancer initiating cells in metastatic melanomas by harnessing the host′s anti tumor humoral immune mechanisms. Journal of Translational Medicine. 12(Suppl 1). O1–O1. 22 indexed citations
7.
Malyguine, Anatoli, Victor Umansky, Beatrix Kotlán, Natalia Aptsiauri, & Michael R. Shurin. (2012). Conference overview: Cancer Immunotherapy and Immunomonitoring (CITIM): Moving forward. Journal of Immunotoxicology. 9(3). 231–235. 1 indexed citations
8.
Kotlán, Beatrix, Viktor Umansky, Anatoli Malyguine, Francesco M. Marincola, & Michael R. Shurin. (2011). Conference Scene: Immunotherapy reaches new milestones in cancer eradication. Immunotherapy. 3(10). 1131–1137. 2 indexed citations
9.
Kotlán, Beatrix & Mark C. Glassy. (2009). Antibody Phage Display: Overview of a Powerful Technology that Has Quickly Translated to the Clinic. Methods in molecular biology. 562. 1–15. 15 indexed citations
10.
Glassy, Mark C., et al.. (2008). Cocktails of human anti-cancer antibodies show a synergistic effect in nude mouse tumor xenografts. Human Antibodies. 16(3-4). 87–98. 5 indexed citations
11.
Kotlán, Beatrix, Vilmos Fülöp, I Szigetvári, et al.. (2006). Alloimmune and Autoimmune Background in Recurrent Pregnancy Loss – Successful Immunotherapy by Intravenous Immunoglobulin. American Journal of Reproductive Immunology. 55(5). 331–340. 22 indexed citations
12.
Kotlán, Beatrix, et al.. (2005). Novel Ganglioside Antigen Identified by B Cells in Human Medullary Breast Carcinomas: The Proof of Principle Concerning the Tumor-Infiltrating B Lymphocytes. The Journal of Immunology. 175(4). 2278–2285. 66 indexed citations
13.
Teillaud, Jean‐Luc, et al.. (2005). Tumor-infiltrating B cell immunoglobulin variable region gene usage in invasive ductal breast carcinoma. Pathology & Oncology Research. 11(2). 92–97. 18 indexed citations
14.
Kotlán, Beatrix, J. Földi, Wolf H. Fridman, et al.. (2004). Immunoglobulin repertoire of B lymphocytes infiltrating breast medullary carcinoma. Human Antibodies. 12(4). 113–121. 20 indexed citations
15.
Gruel, Nadège, et al.. (2003). Generation of scFv from a Phage Display Mini-Library Derived from Tumor-Infiltrating B-Cells. Humana Press eBooks. 193. 281–300. 4 indexed citations
16.
Kotlán, Beatrix. (2001). High anti-paternal cytotoxic T-lymphocyte precursor frequencies in women with unexplained recurrent spontaneous abortions. Human Reproduction. 16(6). 1278–1285. 10 indexed citations
17.
Kotlán, Beatrix, et al.. (2000). A scFv Phage Display Mini Library Generated from the Immunoglobulin Repertoire of Breast Medullary Carcinoma Infiltrating B Lymphocytes. Disease Markers. 16(1-2). 25–27. 6 indexed citations
18.
Kotlán, Beatrix, Nadège Gruel, B Zafrani, et al.. (1999). Immunoglobulin variable regions usage by B-lymphocytes infiltrating a human breast medullary carcinoma. Immunology Letters. 65(3). 143–151. 21 indexed citations
19.
Horuzsko, Anatolij, É Gyódi, Marienn Réti, et al.. (1998). Humoral and cell-mediated factors involved in the suppressive regulation induced by special blood derivatives and their clinical relevance. Transplantation Proceedings. 30(8). 3967–3971. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. G. Natali Breakdown of academic impact, for papers by Fernanda Castro Breakdown of academic impact, for papers by Dave Ankarlo Breakdown of academic impact, for papers by Robin Goldman-Leikin Breakdown of academic impact, for papers by Cornelia Mundt Breakdown of academic impact, for papers by Diana Handke Breakdown of academic impact, for papers by Oezcan Talay Breakdown of academic impact, for papers by Wilson Castro Breakdown of academic impact, for papers by Thomas O. Kleen Breakdown of academic impact, for papers by Donna LeBherz
Rankless by CCL
2026